Market Research Blog – Page 15684 – New Product Development

Mucopolysaccharidosis (MPS) Treatment Market is projected to grow at a robust CAGR of 5.9% between 2022 and 2029

A market study presented by FMI ‘ Mucopolysaccharidosis Treatment Market: Global Industry Analysis 2014-2021 and Opportunity Assessment 2022-2029,’ explains the significant factors influencing the current market structure.

According to research, the mucopolysaccharidosis treatment is still emerging, and different geographies have implemented standard treatment options for the condition. However, there is no universally accepted treatment pattern for mucopolysaccharidosis. Mucopolysaccharidosis falls under rare diseases, which is a complex, diverse, constantly evolving field, and there is a significant shortage of medical and scientific data related to it. Mucopolysaccharidosis treatment and diagnosis involves complex managing requirements, which include long-term care, rehabilitation support, and a continuous treatment plan.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5880

Research Activities Uplift Stem Cell Therapy Application in MPS Treatment

In the present scenario, the drugs that are considered for mucopolysaccharidosis treatment, such as aldurazyme, naglazyme, vimizim, elaprase, mepsevii and hunterase, are the only regulated and recommended drugs present in the market. These drugs fall under enzyme replacement therapies, however, with present research initiatives for stem cell therapies, the latter is considered a prominent mucopolysaccharidosis treatment. Clinical research shows that stem cell transplantation covers a large area that is not covered with the more frequently recommended practice of enzyme replacement therapies, which changes the current market structure for mucopolysaccharidosis treatment, prioritising the latter.

Stem cell therapy is a therapeutic option for mucopolysaccharidosis patients suffering from a severe phenotype, as research shows the method can preserve neurocognition or can even help break the progressive neurodegeneration. The method is provided with strict selection criteria, which is followed by maintained regulations. Research shows that stem cell therapy as a treatment option is gaining popularity among healthcare professionals for mucopolysaccharidosis treatment, which can be attributed to the relation of its better reach towards a normal health condition for the patient.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5880

Enzyme Replacement Therapy Remains Lucrative for Market Investors

As per further assessments of the mucopolysaccharidosis treatment market, it has been difficult to collect epidemiological data pertaining to rare diseases, especially mucopolysaccharidosis treatment, which is likely to impede the actual estimation of the economic burden associated with the condition. The cost estimation for each mucopolysaccharidosis treatment type is affecting and, in turn, creating a more vulnerable situation for the businesses and disrupting research & development activities for each company.

Enzyme replacement therapy is the most attractive segment for investors, however, the unavailability of reimbursement plans and precise treatment plans is encouraging most patient in developing regions to opt for symptomatic treatments instead of enzyme replacement therapy, which is still considered to be the standard mucopolysaccharidosis treatment.

Key Players Focus on Clinical Research of Treatment Models

The report segments the mucopolysaccharidosis treatment market into seven regions to elaborate on the regional trends pertaining to the treatment plan. Major players are focusing on increasing their market share in the Asia Pacific market through strategic collaborations with regional research institutes. There is a lack of awareness about rare diseases among the general public as well as in medical healthcare facilities in several emerging economies. According to a survey and industry report, it takes patients in the US an average of 7.6 years and patients in the UK an average of 5.6 years to actually receive a proper diagnosis. Moreover, it involves a team of healthcare professionals to actually get the right mucopolysaccharidosis treatment and diagnosis pattern for reported cases.

Manufacturers are in the process of introducing a considerable number of mucopolysaccharidosis treatment options, which are currently under clinical trials. An estimated 160 and above clinical trials are being performed for mucopolysaccharidosis treatment. Thus, ensuring that the manufacturers take this mucopolysaccharidosis treatment market to be lucrative and potential rich in terms of revenue. Medical research institutes play an important role in this particular market. They are expected to be the bridge between treatment plans and economical solutions for manufacturers, thus leaving an explicable and lucrative model for mucopolysaccharidosis treatment.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-5880

The mucopolysaccharidosis treatment market includes companies such as BioMarin Takeda Pharmaceutical Company Limited, Sanofi S.A., and Ultragenyx Pharmaceutical Inc. BioMarin accounts for a significant value share in the present mucopolysaccharidosis treatment market. The currently existing promising drug types are expected to face competition from emerging candidates. In addition the mucopolysaccharidosis treatment products of other companies, such as Sangamo Therapeutics, Inc., REGENXBIO Inc., Sarepta Therapeutics, Abeona Therapeutics, Inc., and others, are also in the pipeline.

For a broader lookout of actionable insights on the global market for MPS treatment, write to the analyst at press@futuremarketinsights.com

RFID in Pharmaceuticals Market Key Players, Applications, Outlook, SWOT Analysis And Forecasts By 2028

Future Market Insights (FMI), in its new study, finds that the radio-frequency identification (RFID) in pharmaceuticals market was valued at over US$ 950 Mn in 2018, and is estimated to register a Y-o-Y growth at approximately 10% in 2019. Prospects remain remarkable for the RFID in pharmaceuticals industry, as efficiency-led actions of players continue to enhance the reliability and accuracy of their business operations.

The study finds that drug tracing system remains the most lucrative application of RFID in pharmaceutical industry, accounting for approximately 60% sales. Efforts of the FDA, in collaboration with pharmaceutical suppliers, to maintain a secure drug supply in the wake of rising counterfeit drugs prevalence, has encouraged the pharmaceutical industry to use RFID in combination with the electronic product code (EPC) for real-time tracking, tracing, and authentication of drugs.

According to the study, such preventative measures against infiltration of counterfeit drugs are likely to have a positive economic influence on legitimate companies, who are now focusing on the deployment of anti-counterfeiting solutions. Focus of the organized players in the pharmaceutical sector to safeguard authenticity of their products, while creating moats for counterfeiters, will continue to favour growth of the RFID in pharmaceutical market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9508

Chipless RFID Sales Remain Over 2X of Chipped RFID

According to the study, chipless RFIDs continue to gain robust attractiveness in the pharmaceutical industry, as they eliminate the hardware-related challenges associated with their chipped counterparts. Additionally, RFIDs without ICs allude at significant cost reduction of the component, in turn complementing their development and demand on a wide scale. However, complexities linked with designing and development of chipless RFID, such as data transmission and encoding, continue to sustain the demand for the chipped RFID to a certain extent. The study finds that sales of chipless RFID will remain over 2X that of the chipped RFID in 2019.

The study expects RFID reader to remain the core component in the RFID in pharmaceutical market, with growing focus of pharma suppliers on effective identification of products prior to their collection, storage and shipping. Gains in the RFID in pharmaceutical market will remain complemented by sales of RFID tags, with revenues in 2018 accounting for over one-third market share.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9508

Adoption Remains High among Drug Manufacturers

Application diversity of RFID in pharmaceutical industry has led its adoption among a wide range of end-users that range from drug manufacturers and drug wholesalers, to hospitals and clinics. The report estimates drug manufacturers to account for leading shares of the RFID in pharmaceutical market, who are constantly emphasizing on ensuring the authenticity of their products in the market. Adoption is expected to witness high-growth among drug wholesalers and hospitals and clinics, which collectively account for over two-fifth share of the market.

The study states that North America will remain the leading market for RFID in pharmaceutical, with Europe following the suit. Supremacy of developed economies in the RFID in pharmaceutical market is significantly attributed to stringent standards & regulations implemented for serialization, and relative greater prevalence of OTC and generic drugs in these regions. Additionally, focus of players in developed markets remains strong on brand protection, and preventing packaging-related product recalls, which in turn augurs well for growth of the RFID in pharmaceutical market.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-9508

This FMI study also offers a long-term forecast of the RFID in pharmaceutical market for the period between 2018 and 2028. The RFID in pharmaceutical market is envisaged to record a CAGR of over 8% through 2028. For more, write to press@futuremarketinsights.com

Viscosupplementation Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2030

Global viscosuppplementation revenues are likely to reach USD 4 billion by the end of 2030, according to a new research by ESOMAR-certified firm Future Market Insights.

According to the study, a number of broader, and industry-specific factors will drive growth in this market, which has been relatively less impacted by the sluggishness induced by COVID-19.

As per the UN, by 2050, those aged 60 and above will account for over 20% of the global population. In other words, the UN says that by 2050 around 130 Mn people will contract osteoarthritis. These numbers point towards growth in the viscosupplementation market in the forecast period.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

Covid-19 Pandemic: Viscosuppplementation Market Players Consolidating their Position

The ongoing Covid-19 pandemic has compelled the market players to take a consistent path for the next two quarters. As it would take some time for the healthcare vertical to look through new product launches; the players are looking at ways to smoothen the supply chain as manpower has taken a hit.

Continuous innovations are expected to propel the growth of viscosupplementation market” says the FMI analyst

Key Takeaways of Viscosupplementation Market Study

Three injection viscosuppplementation is expected to contribute for more than 55% of revenue share
Knee osteoarthritis is expected to gain around one-third of market share during the forecast period
North America is the highest revenue generating market due to scientific advancements and high adoption of viscosuppplementation

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9509

New Product Development to be the Torchbearer

The market players are into the innovation mode to strengthen their foothold in the viscosupplementation market. This competitive landscape is all set to create ripples all across the market. Some of the innovations are:

Fidia Pharma USA Inc., in 2019, introduced a HA (Hyaluronic Acid) based intra-articular viscosupplement called “TRILURON” to treat knee osteoarthritis. The treatments cycle involves 3 injections at weekly intervals.
Japan-based Seikagaku Corporation, in Mar 2019, launched an intra-articular single-injection viscosupplement called “HyLink” in Italy for treating knee osteoarthritis.
Recently, Gel-One Hyaluronate was approved as one of the injectable gels to treat osteoarthritis of knee. The pre-market clinical study reported no pseudosepsis (severe acute inflammatory responses).

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-9509

Want more insights?

Viscosupplementation market, a new study from Future Market Insights, opines on the viscosupplementation from 2015 – 2019 and presents demand projections from 2020 – 2030 on the basis of; product types (single injection viscosupplementation, three injection viscosupplementation, and five injection viscosupplementation), application (knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, and others such as elbow and ankle joint osteoarthritis), and end user (hospitals, ambulatory surgical centers, orthopedic clinics, retail pharmacies, and online sales) across seven prominent regions.

Vision Screeners Market is expected to grow at a CAGR of 5.9% during the forecast period 2022-2029

Global vision screener sales are likely to near US$ 500 Mn by the end of 2022. According to a new research intelligence study presented by Future Market Insights (FMI), the market for vision screeners will continue to witness an average 5.5% Y-o-Y growth in the revenues in 2022 and ahead. As reported by the study, more than a third of overall sales of vision screeners is targeted to a variety of vision screening tests, followed by color vision tests.

While portable or handheld vision screening devices have been sought after over the years, it is more likely that the vision screening software will experience rapid gains in coming years, as a result of brisk technological penetration. Moreover, as key manufacturers are investing considerable efforts in technological innovations of vision screeners, table-top variants are also likely to see healthy sales growth in the near future. Currently, more than 50% of the total sales are accounted by portable or handheld devices that are used during vision screening procedures, as per the report.

The rising prevalence of vision problems, advancements in technology, increasing healthcare spending, and the growing prevalence of diabetes constitute some of the key factors responsible for driving the global vision screeners market revenues.

In addition to some of the most commonplace vision disorders, newly establishing problems such as digital eye strain (more popularly, computer vision syndrome) are strongly necessitating the demand for efficient vision screening tests, particularly among the younger population. This, according to FMI’s analysis, will drive sales of vision screeners in the forthcoming years.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5032

Inadequate Effectiveness of Vision Screening Tests Prevails in Developing Asian Markets

Accounting for a collective value share of over 60%, North America and Europe will continue to lead the pack in global vision screeners market. In addition to early adoption of advanced technologies and high awareness about vision problems and the significance of vision screening, the growth of market in these regions has been prominently attributed to the rapid consolidation of healthcare facilities within these regions.

On the other hand, dearth of skilled and trained professionals in the field of vision screening will remain the prime factor restraining vision screeners adoption across developing Asian countries. Relatively lesser competency to professionally and accurately assess vision screening results continues to pose significant barriers in the growth path of market within Asia Pacific (APAC).

According to the report, a sizeable number of vision screening tests cannot be performed on children who have reading problems such as hyperopia or astigmatism. As a result, the ineffectiveness of vision screeners continues to negatively influence the number of parents opting for pediatric vision screening tests, which is further a significant factor deterring the revenues of vision screeners market in APAC.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5032

Pediatric Vision Screening Emerging as a Prime Focus Area for Innovations

Some of the key players competing in the global vision screeners market landscape include Hill-Rom Holdings, Inc. (Welch Allyn), Essilor International S.A. (Stereo Optical Company Inc.), Adaptica S.r.l., OCULUS Surgical, Inc., Plusoptix Inc., Honeywell International Inc., FIM Medical SAS, SHANGHAI TOP VIEW INDUSTRIAL CO., LTD., Thomson Screening Solutions Ltd., and Keystone View. While a majority of these companies are concentrating in technological upgrades of the current offerings, augmented investments targeting FDA approvals will be an important strategy.

Moreover, multiple longstanding challenges prevailing in children’s vision screening are highly likely to push the scope for innovations, which would help overcome the challenges and extend the efficiency of vision screening – specifically for children. The FMI study reveals how the companies that are manufacturing, supplying, and distributing vision screeners are strategizing on the growing traction in the pediatric patients segment.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-5032

To offer an exclusive outlook of the most influential trends and opportunities shaping the vision screeners industry landscape, the report has examined the market for a 10-year projection period, 2022-2029. To know more, write in to the analyst at press@futuremarketinsights.com

Pharmaceutical Intermediates Market to grow at 4.3% CAGR through 2030

The rapidly increasing prevalence of chronic diseases around the world is expected to fuel the need for novel drugs and better treatment option would further drive the growth of the global market. Due to increasing demand for novel drugs option, there has been rising applications of drug intermediates and growing adoption and in the field of research and clinical studies.

Leading players in the biotechnology and pharmaceutical sectors along with research institutes are now increasingly focusing on R&D activities relating to drug creation and development. Future Market Insights (FMI) in a new study has forecast the global pharmaceutical intermediates to reach US$ 30 Bn in 2020, with the market predicted to exhibit a CAGR of 4% during the forecast period (2020-2030)

Pharmaceutical intermediates are used in during manufacturing of bulk drugs as raw materials. These are the material produced during the synthesis of an active pharmaceutical ingredient (API). However, pharmaceutical and biotech companies can make use of these drug intermediates for the purposes of research and development (R&D). Moreover, there are different forms of pharmaceutical intermediates available such as high quality pharmaceutical intermediates, moderate quality pharmaceutical intermediates and premium quality intermediates. The high-quality and premium pharmaceutical intermediates are mainly used for R&D activities.

COVID-19 pandemic is negatively impacting pharmaceutical intermediates sales due to supply chain disruptions caused due to extended period of lockdown. Nonetheless growth is expected to recover because an increasing number of pharma companies are engaging in research and development to find effective treatment and vaccination for COVID-19 virus.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4515

Key Takeaways from Pharmaceutical Intermediates Marker Study

The demand for chiral intermediates will continue rising through the forecast period
East Asia will dominate in the global pharmaceutical intermediates market. China is expected to emerge as the most lucrative market for pharmaceutical intermediates in the region.
Analgesics to remain primary application, expanding at Y-o-Y rate exceeding 6% through 2020
The demand for Generic Drug Intermediates is expected to be higher than Branded Drug Intermediates
Biotech and Pharma Companies will continue exhibiting high demand for pharmaceutical intermediates

“Rising drug development activities worldwide as well as increasing adaption of pharmaceutical intermediates as raw material are driving the growth of global Pharmaceutical Intermediates market” says the FMI Analyst

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4515

Acquisitions, Partnerships and expansion are key Strategic Focus of Pharmaceutical Intermediates Market Players

Leading players in the Pharmaceutical Intermediates market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

On April 2018, strategic collaboration between Porton Pharma Solutions, Ltd. And Codexis, Inc. to use Codexis’ biocatalyst technology within Porton’s global custom active pharmaceutical ingredients (API) and intermediate for manufacturing business.
On June 2017, BASF SE is expanding its production capacity at Texas site, whereas it is also constructing new Ibuprofen API facility in Ludwigshafen, Germany, which is expected to be functional in 2021.

Key Participant Insights

The global market is set to expand its scope in the forecast period, due to rising prevalence of chronic disease globally and adoption of Pharmaceutical Intermediates at various stages of drug development by pharmaceutical manufacturers. In addition to this, cost effectiveness and rise in alternate methods for purification of oligonucleotide has augmented the sales of Pharmaceutical Intermediates.

The key market players covered by FMI include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, Codexis, Lianhe Chemical Technology Co., Ltd, Sanofi S.A, Dishman Group And BASF SE, And Chemcon Speciality Chemicals Pvt. Ltd consolidating their positions through mergers, acquisitions and new product launches.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-4515

Pharmaceutical Intermediates Market – Key Segments

Product

Chemical Intermediates
Bulk Drug Intermediates
Custom Intermediates

Category

Branded Drug Intermediates
Generic Drug Intermediates

Application

Analgesics
Anti-inflammatory Drug
Cardiovascular Drugs
Anti-diabetic Drugs
Antimicrobial Drugs
Anti-cancer Drugs
Others

End User

Biotech and Pharma Companies
Research Laboratory
CMOs/CROs

Agriculture Nets Market 2022 Assessment and Key Insights Analyzed Till 2030

Future Market Insights (FMI) forecast the global agriculture net market to surpass US$1.0 Bn in 2020, and projected to register a CAGR of 5% during the forecast period 2020 and 2030.

An incredible shift towards improving crop yield to avoid dependency on imports has upped the demand for agriculture nets. These nets have an extensive usage in commercial as well as sustainable farming, becoming a support system in ensuring healthy growth of crops.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12302

Locust attacks, erratic weather patterns characterized by heavy hail and rain, heat, and penetration of UV rays has created a massive need for demand of agriculture nets in recent years. Developed in various grades, these nets ensure limited penetration of heat and UV rays, which keeps the temperature inside the greenhouse optimum for growth of plants.

The global agriculture net market is also flourishing as urban dwellers are taking up gardening as a serious hobby with lucrative returns. A turn towards building urban jungles and sustainable living with kitchen gardens has generated a high demand for agriculture nets or shade nets.

global agriculture nets market region wise plc position and notable trends

The most imminent reason for burgeoning sales of agriculture nets is that it ensures reduced UV penetration, thus keeping the yield away from overexposure and damage. Today, vendors are also investing in designing agriculture nets that enhance photosynthesis, thus helping the end users create a healthy ecosystem for the plants.

Key Takeaway from Agriculture Net Market Study

Plastic to emerge as the leading material used in the production of agriculture nets during the forecast period
Farming to remain principal activity that uses agriculture net, occupying a dominant share in the global market
Rise of construction activities to raise demand for agriculture net for effecting coverings to prevent exposing unfinished buildings to excessive moisture
South Asia to see stiff competition in the agriculture net market due to influx of local players and presence of established ones

“The demand for agriculture nets will be felt from the expanding aquaculture industry as end users are looking at innovative ways to build effective bird netting. Need to ensure excellent predator control for building breeding grounds is expected to extend usage of agriculture nets in aquaculture industry,” says FMI analyst.

Community-driven Initiatives for Vermicomposting Creates New Growth Avenue

Growing number of urban communities are showing an inclination towards vermicomposting, which is a delicate task has led to a steady rise in the demand for agriculture nets. These nets act as perfect dividers for making pits and can be used as canopies to create shade.

The delicate balance of light and shade that needs to be maintained for correct moisture levels in building healthy vermi compost pits is projected to drive market growth. Growing number of kitchen gardens and increasing demand for better waste management have introduced vermi compost as an effective solution. Analysts project that as these trends continue, they will continue to raise the usage of agriculture nets in the coming years.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12302

Impact of COVID-19 on Global Agriculture Nets Market

The COVID-19 pandemic has had a moderate impact on the global agriculture net market. While the demand for these nets plummeted in the construction industry, it was offset by the demand in the agriculture sector. The lockdowns and disrupted supply chains indicated that self-reliance with agriculture will be of paramount importance to avoid dependency on other nations for imports.

COVID-19, which led to severe lockdowns, also fuelled many to work on hobbies, creating a demand for shade nets for gardening. The sudden rise in number of enthusiasts building terrace gardens are expected to favour market growth in the coming years. Furthermore, as the pandemic situation normalizes, farmers will invest in agriculture nets to boost production.

Get Valuable Insights into Global Agriculture Net Market

Future Market Insights, in its new offering, provides an unbiased analysis of the global agriculture net market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2020-2030. The study divulges compelling insights on the global agriculture net market based on net type (shading nets, anti-hail, anti-insects, windbreak, and others), form (woven and non-woven), application (farming area, animal husbandry, horticulture and floriculture, aquaculture, and others), end use (industrial agriculture and sustainable agriculture), price range (economic, mid-range, and premium), material (metal, plastic, rubber, and others), sales channel (hypermarkets/supermarkets, specialty stores, departmental stores, independent stores, hardware stores, farm equipment stores, and others), and region (North America, Europe, the Middle East and Africa, East Asia, South Asia, Oceania, and Latin America).

Key Segment

Type

Shading Nets
Anti-hail
Anti-insects
Windbreak
Others

Form

Woven
Non-woven Form

Application

Farming Area
Animal Husbandry
Horticulture and Floriculture
Aquaculture
Others

End Use

Industrial Agriculture
Sustainable Agriculture

Price Range

Economic
Mid-range
Premium

Material Type

Metal
Plastic
Rubber
Others

Sales Channel

Hypermarkets/Supermarkets
Specialty Stores
Departmental Stores
Independent Stores
Hardware Stores
Farm Equipment Stores
Other Sales Channel

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/12302

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Shrimps Disease Diagnostics Market Insights, Deep Analysis of Key Vendor in the Industry 2022-2029

This Shrimps Disease Diagnostics market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Shrimps Disease Diagnostics market.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9922

Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases. Disease problems in shrimp production are poorly understood and diagnosed. Various shrimps diseases such as white spot diseases highly affect shrimp production and continue to pose a serious challenge. Diagnosis of that disease is very important. There is no therapeutic option available for viral diseases and the only option available to detect and avoid the pathogen entry into culture systems. DNA based diagnostic tool such as PCR used to test. Diagnosis tools and technologies are gaining demand for the quick and effective diagnosis of shrimp diseases for management of disease outbreaks. Assay based kits and rapid test kits are available for the shrimp’s disease diagnostic market.

Shrimps Disease Diagnostics Market: Drivers and Restraints-

Growing demand for shrimps for human consumption and nutrient purpose is the major favor expected to boost up the growth of shrimps disease diagnostics market. Rising demand for the freshwater and marine shrimp farming is the major driving factor of the shrimps disease diagnostics market. Increasing global production of the shrimp propels the growth of the shrimps disease diagnostic market. Technological advancement in the field of aquaculture disease diagnosis drives the growth of the shrimps disease diagnostic market.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9922

Shrimps Disease Diagnostics Market: Overview

Viruses such as white spot syndrome virus, Taura syndrome virus, yellow head/gill-associated virus, infectious myonecrosis virus, mourilyan virus, necrotising hepatopancreatitis bacteria, infectious hypodermal and hematopoietic virus are the major cause of shrimp diseases. Based on reagent kits shrimps disease diagnostics market is segmented into assay based kits and rapid testing kits Based on end-user shrimps disease diagnostics market is segmented into fisheries, aquaculture laboratories, marine laboratories, education and research institutes, and others. Aquaculture laboratories expected to contributes prominent revenue share in the shrimps disease diagnostics market.

Shrimps Disease Diagnostics Market: Region-wise Outlook

Asia Pacific expected to dominated the shrimps disease diagnostics market as high production rate in China and India. About 30% of farmed shrimp is produced in Asia, particularly in China and Indonesia. Shrimps disease diagnostics market expected to represent prominent growth in the countries such as United States, Japan and Western Europe. Growing consumption of shrimps in the food and strict regulatory policies regarding food safety in the countries such as U.S. and Japan expected to boost up the growth of the shrimps disease diagnostics market.

Shrimps Disease Diagnostics Market: Key Market Participants

Example of certain market players participants in global shrimps disease diagnostics market find across the value chain are HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., Thermo Fisher Scientific, Lab – Ind Resource Sdn Bhd., AquaBounty Technologies, Inc., GeneReach Biotechnology Corp., pop bio, SUREBIO, Auro Biotechnologies and others.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (India, China ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Shrimps Disease Diagnostics Market: Segmentation

On the basis of reagent kits, shrimps disease diagnostics market can be segmented as:

Assay Based Kits
Rapid Testing Kits

On the basis of disease type, shrimps disease diagnostics market can be segmented as:

WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)

On the basis of end user, shrimps disease diagnostics market can be segmented as:

Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/9922

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Contact Us:

Specimen Radiography Systems Market : Notable Developments & Geographical Outlook 2022 to 2029

Specimen radiography systems is a medical device which is used for imaging the breast biopsy cores. Also surgically excise tissue specimen will be analyzed using specimen radiography systems. Specimen radiography systems are available in in for standalone and portable form. Specimen radiography systems include 8-by-8-inch camera and 16-bit contrast resolution which provide clear imaging of breast biopsy. Along with that, Specimen radiography systems consist of a lighted specimen X-ray chamber, X-ray automatic exposure controls, and large active imaging area. Smallest micro clarification of large specimen can be done by using specimen radiography systems. Specimen radiography systems can also generate the HD images of specimen and can send these images directly to PCAS. The use of specimen radiography systems for mammographic screening have improved the diagnostic method and provide an advent for early detection of breast cancer.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10411

Specimen Radiography Systems Market: Drivers and Restraints

Rising prevalence of breast cancer is the primary factory driving the growth of Specimen Radiography Systems market. Also, rising adoption of specimen radiography systems for mammographic screening will fuel the growth of Specimen Radiography Systems market. Moreover, technological advancements also boosting the revenue growth for Specimen Radiography Systems market. Additionally, availability of favourable reimbursement scenario for the treatment of breast cancer will upsurge the demand for Specimen Radiography Systems market. Additionally, rising awareness among the people about the breast cancer due launch of several awareness campaign by NGO in both developed and developing countries. On other hand, Uncertainty in product approval by FDA can restrain the growth of Specimen Radiography Systems market.

Specimen Radiography Systems Market: Overview

The specimen radiography systems market is expected to show exponential growth over the forecast period due to rising patient pool suffering from of breast cancer. Breast cancer is the most common cancer among the woman as the research by World Cancer Research Fund International. The same organization also stated that 19.3 per 100,000 women are suffering from breast cancer throughout the globe. According to Union Health Ministry of India, around 25.8 per 10,000 women are suffering from cancer in India. Among all end user breast clinics segment of tissue market is anticipated to grow at faster pace that other segment over the forecast period.

Specimen Radiography Systems Market: Regional Overview

North America is expected to be most dominant region for Specimen Radiography Systems market due technological advancement in U.S. and Canada. After North America, Specimen Radiography Systems market is then followed by Europe owing to increasing adoption for Specimen Radiography Systems and availability of favorable reimbursement scenario in this region. Asia-Pacific is expected to show significant growth for Specimen Radiography Systems market due rising prevalence of breast cancer in India and China. Latin America and Middle East and Africa region are expected to show delayed growth for Specimen Radiography Systems market owing to lack awareness among the people in this region.

Specimen Radiography Systems Market: Key Players

Examples of some of the market participants in Specimen Radiography Systems market identified across the value chain Progressive Medical Corp., Hologic, Inc., Simeks T?bbi Sistemler Sanayi ve Ticaret A.?., KUB Technologies, and others.

The research report on Specimen Radiography Systems market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on Specimen Radiography Systems market provides analysis and information according to market segments such as geographies, application, and industry.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-10411

The report covers exhaust analysis on Specimen Radiography Systems Market:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Report on Specimen Radiography Systems market includes regional analysis:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Europe (Germany, Italy, France, U.K, Spain, , Russia)
East Asia (China, Japan, South Korea)
South Asia (India, ASEAN)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC Countries, South Africa, Northern Africa)

Specimen Radiography Systems Market: Segmentation

The global Specimen Radiography Systems market is classified on the basis of modality, end user and geographic region

Based on modality, Specimen Radiography Systems market is segmented into following:

Trolley Mounted
Wall Mounted

Based on end user, Specimen Radiography Systems market is segmented into following:

Hospitals
Breast Clinics
Ambulatory Surgical Centers

Report on Specimen Radiography Systems market highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/10411

Contact Us:

Donor Egg IVF (In-Vitro Fertilization) Market is projected to grow at a robust CAGR of 7.7% between 2022 and 2028, reaching nearly US$ 4.47 Bn by 2028

Adoption of donor egg IVF treatment accounted for the approximate revenue of US$ 2 billion in 2021, which are likely to witness a healthy spike by 6.7% in 2022. Future Market Insights (FMI) recently presented a research study on the global donor egg IVF market, according to which a majority of overall adoption is registered at fertility clinics and IVF centers.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2499

A Majority of Patients Seek Donor Egg IVF Treatment at Fertility Clinics & IVF Centers

Donor egg IVF is a procedure in which technological and pharmacological manipulation is used to help and promote pregnancy, the procedure has gained significant ground globally, in recent years. Donor egg IVF has rapidly become one of the most sought after fertility treatment alternatives among the infertile population.

The study opines that fresh donor egg cycle has been preferred over frozen donor egg cycle, attributed to the associated high rates of pregnancy and successful births. Currently, nearly 70% of donor egg IVF treatment adoption is recorded at IVF centers and fertility clinics, and more than 70% of the times, the procedure is conducted by using fresh donor egg cycle.

In the fresh donor egg cycle, eggs are retrieved, following which they are fertilized immediately and directly transferred to the recipient’s womb (uterus). The birth rate and pregnancy rate by using fresh donor egg cycle are estimated to be more than 36% and 55%, respectively. On the flipside, the birth rate and pregnancy rate by using a frozen donor egg cycle are just about 24% and 39%, respectively. According to the report, enhanced pregnancy and birth rates will continue to advocate preference for fresh donor egg IVF over frozen.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-2499

The Rising Burden of Infertility Pushing Scope of Egg Donor IVF Adoption

As concluded by FMI’s analysis, with an increasing number of couples postponing first pregnancy that generally leads to higher prevalence of age-related infertility issues, it is highly likely that procedures such as in-vitro fertilization (IVF) and a step ahead, donor egg IVF, will continue to witness robust demand in years to come.

Research has proven that the number of women with ovaries that have untimely ceased to function has been on a considerable rise over the recent past, and thus, donor egg remains the only chance for them to conceive and lead a successful pregnancy period. The increasing infertility burden is complemented by a strong increase in the number of female egg donors, which has been cited as another important factor pushing prospects of donor egg IVF market.

Europe’s donor egg IVF market is expected to witness strong growth in forthcoming years, followed by North America, as a result of high inbound of infertile population opting for fertility treatment, across the region. Moreover, the expensive costs of donor egg IVF treatment and favorable government initiatives and reimbursements on the same are accounting for prominence of these regions in global donor egg IVF industry. The report also indicates that donor egg IVF market in Asia Pacific will demonstrate high growth potential through the coming years, as a considerably large patient pool is seeking fertility solutions.

A majority of European countries offer good service at a reasonable budget for donor egg IVF procedures and some countries, such as Brazil and Australia, reimburse 50% of the treatment cost for unsuccessful donor egg IVF procedures, or reimburse other expenses such as accommodation or out-of-pocket costs for egg donors.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-2499

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Disposable Spinal Instruments Market is poised to increase at a robust CAGR of 8.3% between 2022 and 2028

Healthcare-Associated Infections or Hospital-Acquired Infections (HAIs) are caused while receiving medical treatment in a hospital facility. HAIs are among the major challenges to the safety of patients, and can have severe public health implications. These infections are also capable of causing disability and sometimes death. The occurrence of HAIs is increasing at an alarming rate. According to WHO, the prevalence of these infections in developed countries varies from 3.5% to 12%. Developing countries are at a higher risk as the rate of infection is 3-20 times higher in developing countries as compared to high-income countries.

In the U.S., more than 15 Mn surgeries are performed annually. Between 2% and 5% of patients are estimated develop a surgical site infection, which is between 160,000 and 300,000 surgical site infections nationwide each year. Surgical site infections are among the most commonly occurring HAIs in the U.S., and are the most expensive to treat. Fortunately, the adoption of various disposable devices and kits has reduced the incidence of surgical site infections and HAIs.

Thus, the increasing preference for the usage of disposable instruments for reducing the occurrence of HAIs is driving the demand for disposable instruments, which is creating growth opportunities for the disposable spinal instruments market.

According to latest research by FMI, the global disposable spinal instruments market is estimated to have accounted for US$ 43.7 Mn in terms of value in 2021. The report on the disposable spinal instruments market further projects that the disposable spinal instruments market is likely to grow at a CAGR of 8.2% during the period 2022-2029.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6890

The demand for disposable instruments kits in the healthcare industry is growing at a significant rate, and the demand from unconventional end-use industries is one of the major factors fuelling the market for disposable spinal instruments. Growth in the number of end users, apart from hospitals, such as orthopaedic clinics and Ambulatory Surgical Centres (ASCs), is expected to create high demand for disposable spinal instruments. Moreover, the adoption of disposable instrument kits by various end users has reduced the risk of infections and cross-contamination, which has resulted in a reduction in the number of HAIs.

Increase in the number of use cases of disposable spinal instruments in hospitals and ASCs is expected to boost the global demand for disposable instrument kits. According to CDC, the number of Medicare-certified ASCs has increased steadily from 239 in 1983 to 5,316 in 2010.

Moreover, increasing geriatric population, which is prone to various types of spinal injuries, is estimated to boost the need for surgeries. This is expected to contribute to the demand for disposable spinal instruments. The increasing requirement of instrument kits during surgeries among the greying population, coupled with improved life expectancy, has created significant growth opportunities for the manufactures of disposable spinal instruments market. However, factors such as stringent regulations and the generation of a significant amount of waste due to the usage of disposable kits is expected to lower the growth of disposable spinal instruments in the forecast period.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-6890

The disposable spinal instruments kits segment is a leading segment in terms of revenue by product type in the disposable spinal instruments market, with a 64.5% revenue share in 2021. These kits are most widely used in cervical and lumbar surgeries such as spinal fusion and decompression surgeries. Among the procedure type segments, the spinal fusion sub-segment accounts for the largest revenue share in the disposable spinal instruments market. Among all the end users in the disposable spinal instruments market, the hospitals sub-segment is expected to be a prominent segment, followed by the orthopaedic clinics sub-segment.

The disposable spinal instruments market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America, followed by Europe, is a prominent region in the global disposable spinal instruments market. North America accounted for a revenue share of 45.8% in 2021 in disposable spinal instruments market. Europe, accounting for the second-largest revenue share, is followed by East Asia in the disposable spinal instruments market. India, China, and Brazil are emerging markets in the disposable spinal instruments market. China is one of the fastest-growing emerging markets in the global disposable spinal instruments market, and is projected to grow at a CAGR of 11.2% over the forecast period of 2022-2029.

The disposable spinal instruments market report tracks some of the key companies operating in the disposable spinal instruments market, such as ECA Medical, Providence Medical Technology, Inc., Xenco Medical, Paradigm Spine, Intelligent Implant Systems, LLC, Safe Orthopaedics, SA , TeDan Surgical Innovations, LLC, and Joimax GmbH. Majority of the regional players in the disposable spinal instruments market are focused on increasing their product reach and connectivity with the regional distributors of disposable spinal instruments. The manufacturers of disposable spinal instruments are focusing on collaborating with established hospitals and ASCs to sell products as some of the medical practitioners are particular about the type and brand of products used for a surgical procedure.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-6890

About Future Market Insights (FMI)